Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Thomas Kartika

Concepts (73)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thrombosis
5
2026
400
1.210
 Why?
Platelet Aggregation
2
2026
99
0.980
 Why?
Platelet Membrane Glycoproteins
1
2026
31
0.970
 Why?
Receptors, IgG
1
2026
77
0.950
 Why?
Receptors, Cell Surface
1
2026
372
0.820
 Why?
Blood Platelets
2
2026
379
0.790
 Why?
Hirudins
1
2023
53
0.790
 Why?
Fibrinolytic Agents
1
2026
297
0.780
 Why?
Protein Kinase Inhibitors
3
2026
981
0.750
 Why?
Extracorporeal Membrane Oxygenation
2
2023
390
0.720
 Why?
Venous Thrombosis
2
2022
196
0.300
 Why?
Neoplasms
5
2023
2906
0.300
 Why?
Venous Thromboembolism
2
2023
328
0.270
 Why?
Genetic Diseases, X-Linked
1
2026
26
0.240
 Why?
Agammaglobulinemia
1
2026
36
0.240
 Why?
Clot Retraction
1
2025
2
0.220
 Why?
Drug Repositioning
1
2025
39
0.220
 Why?
Small Molecule Libraries
1
2025
111
0.200
 Why?
Hematology
1
2023
21
0.200
 Why?
Hematologic Diseases
1
2023
66
0.190
 Why?
High-Throughput Screening Assays
1
2025
176
0.190
 Why?
von Willebrand Diseases
1
2023
28
0.190
 Why?
General Practice
1
2022
32
0.180
 Why?
Heparin
1
2023
247
0.180
 Why?
Hemostatics
1
2023
64
0.180
 Why?
Cyclin-Dependent Kinase 4
1
2022
53
0.170
 Why?
Cyclin-Dependent Kinase 6
1
2022
49
0.170
 Why?
Hemorrhage
2
2023
822
0.170
 Why?
Lymphoma
1
2022
237
0.160
 Why?
Platelet Aggregation Inhibitors
1
2025
499
0.160
 Why?
Transplantation, Autologous
1
2022
300
0.160
 Why?
Bone Marrow Transplantation
1
2022
298
0.160
 Why?
Recombinant Proteins
1
2023
1368
0.160
 Why?
Respiratory Insufficiency
1
2023
326
0.150
 Why?
Peptide Fragments
1
2023
693
0.150
 Why?
Breast Neoplasms
2
2023
2382
0.150
 Why?
Anticoagulants
1
2023
748
0.140
 Why?
Tissue and Organ Procurement
1
2022
343
0.130
 Why?
Hematopoietic Stem Cell Transplantation
1
2022
699
0.110
 Why?
Humans
14
2026
145474
0.100
 Why?
Retrospective Studies
4
2023
17291
0.090
 Why?
Signal Transduction
1
2026
5216
0.090
 Why?
Antineoplastic Agents
1
2020
2214
0.070
 Why?
Immunotherapy
2
2022
666
0.060
 Why?
Hematologic Tests
1
2023
22
0.050
 Why?
Adult
2
2023
40777
0.050
 Why?
Deamino Arginine Vasopressin
1
2023
15
0.050
 Why?
Catheterization
1
2023
183
0.050
 Why?
von Willebrand Factor
1
2023
85
0.050
 Why?
Hormone Replacement Therapy
1
2023
107
0.050
 Why?
Hemostasis
1
2023
98
0.050
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Transplantation, Homologous
1
2022
418
0.040
 Why?
Estrogens
1
2023
367
0.040
 Why?
B7-H1 Antigen
1
2022
244
0.040
 Why?
Probability
1
2020
307
0.040
 Why?
Consensus
1
2022
477
0.040
 Why?
Flow Cytometry
1
2022
1162
0.030
 Why?
Risk Factors
2
2023
10885
0.030
 Why?
Medical Oncology
1
2020
339
0.030
 Why?
Precision Medicine
1
2020
459
0.030
 Why?
Anxiety
1
2023
1118
0.030
 Why?
Disease Progression
1
2023
2864
0.030
 Why?
Biomarkers, Tumor
1
2022
1321
0.030
 Why?
Registries
1
2023
2406
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2023
1963
0.020
 Why?
Cohort Studies
1
2023
6013
0.020
 Why?
Risk Assessment
1
2022
3747
0.020
 Why?
Middle Aged
2
2023
36215
0.020
 Why?
Aged, 80 and over
1
2023
8333
0.020
 Why?
Mutation
1
2022
4075
0.020
 Why?
Female
2
2023
78844
0.010
 Why?
Aged
1
2023
26153
0.010
 Why?
Kartika's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (73) concept(s)
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)